Progress in chemotherapy of multidrug-resistant tuberculosis
Multidrug-resistant tuberculosis(MDR-TB)means that Mycobacterium tuberculosis is resistant to at least two first-line anti-tuberculosis drugs,including isoniazid and rifampicin.Because of its long course of tuberculosis,high economic burden,low cure rate and great differences in drug resistance in different coun-tries and regions,this disease has posed great challenges to the global tuberculosis prevention and control.Therefore,it is an urgent task to actively explore the effective treatment of multidrug-resistant tuberculosis.At present,chemotherapy is yet the main treatment for MDR-TB.This paper expounds on chemotherapy for MDR-TB,and discusses the existing limitations and shortcomings in order to provide some reference for clini-cal treatment and multidisciplinary cooperation of MDR-TB.
国家科技期刊平台
NSTL
万方数据
